Analysis of viral infection and innate immune response using humanized mice
Project/Area Number |
24390112
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Partial Multi-year Fund |
Section | 一般 |
Research Field |
Virology
|
Research Institution | Kyoto University |
Principal Investigator |
|
Project Period (FY) |
2012-04-01 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥18,720,000 (Direct Cost: ¥14,400,000、Indirect Cost: ¥4,320,000)
Fiscal Year 2014: ¥6,240,000 (Direct Cost: ¥4,800,000、Indirect Cost: ¥1,440,000)
Fiscal Year 2013: ¥6,110,000 (Direct Cost: ¥4,700,000、Indirect Cost: ¥1,410,000)
Fiscal Year 2012: ¥6,370,000 (Direct Cost: ¥4,900,000、Indirect Cost: ¥1,470,000)
|
Keywords | ヒト化マウス / ウイルス制御因子 / HIV / tetherin / APOBEC3 / アクセサリ蛋白質 / Vif / シチジン脱アミノ酵素 / Vpr / 制御性T細胞 / Treg / HTLV |
Outline of Final Research Achievements |
Using a human hematopoietic stem cell-transplanted humanized mouse model, we found a series of HIV-1 infection mechanisms. Vpu contributes to efficient spread of HIV-1 in vivo. Vpu concomitantly downregulates tetherin and CD4 from the surface of infected cells. Vpr induces depletion of CCR5+ FOXP3+ CD4+ regulatory T cells (Treg) for enhancing viremia of CCR5-tropic HIV-1. APOBEC3F and APOBEC3G fundamentally work as restriction factors against HIV-1 in vivo, but at the same time, that APOBEC3F are capable of promoting viral diversification and evolution in vivo.
|
Report
(4 results)
Research Products
(26 results)
-
-
[Journal Article] APOBEC3D and APOBEC3F Potently Promote HIV-1 Diversification and Evolution in Humanized Mouse Model2014
Author(s)
Sato, K. Takeuchi, J. S. Misawa, N. Izumi, T. Kobayashi, T. Kimura, Y. Iwami, S. Takaori-Kondo, A. Hu, W. S. Aihara, K. Ito, M. An, D. S. Pathak, V. K. Koyanagi, Y.
-
Journal Title
PLoS Pathog
Volume: 10
Issue: 10
Pages: e1004453-e1004453
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
-
-
-
-
-
[Journal Article] Oral administration of the CCR5 inhibitor , maraviroc, blocks HIV ex vivo infection of Langerhans cells within the epithelium2013
Author(s)
Matsuzawa T, Kawamura T, Ogawa Y, Takahashi M, Aoki R, Moriishi K, Koyanagi Y, Gatanaga H, Blauvelt A, Shimada S
-
Journal Title
J Invest Dermatol
Volume: 133(12)
Issue: 12
Pages: 2803-5
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-
-
[Presentation] APOBEC3F potently promotes HIV-1 diversification and evolution in humanized mouse model2014
Author(s)
Sato, K., Shibata, J., Izumi, T., Misawa, N., Kobayashi, T., Kimura, Y., Ito, M., Pathak, V. K., Koyanagi, Y.
Organizer
Cold Spring Harbor Laboratory Meeting on Retroviruses
Place of Presentation
New York
Year and Date
2014-05-19 – 2014-05-24
Related Report
-
[Presentation] Differential impact of HIV-1 G-to-A hypermutation Induced by APOBEC3G and APOBEC3F in vivo2013
Author(s)
Sato K., Shibata J., Izumi T., Misawa N., Kobayashi T., Kimura Y., Ito M., Pathak K.V., Koyanagi Y.
Organizer
38th Retroviruses Meeting Cold Spring Harbor
Place of Presentation
Cold Spring Harbor, New York, USA
Related Report
-
-
-
-
-
-
-
-
-